TDRL-551

• Description:

  TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung and ovarian cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  591.83

• Molecular Formula:

  C25H23ClIN3O4

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1644626-43-6